232 related articles for article (PubMed ID: 16312303)
1. Comparative in vitro activity of imipenem and nine other antimicrobials against recently isolated pathogens.
Bonadio M; Maccanti O; Cosci S; Giordani R
J Chemother; 1989 Jul; 1(4 Suppl):58-60. PubMed ID: 16312303
[No Abstract] [Full Text] [Related]
2. In vitro antibacterial activity of imipenem and other agents against gram-negative and gram-positive strains isolated from clinical specimens.
Bartoloni A; Colao MG; Giganti E; Orsi A; Aquilini D; Corti G; Paradisi F
G Ital Chemioter; 1988; 35(1-3):1-5. PubMed ID: 3256508
[No Abstract] [Full Text] [Related]
3. Comparative in vitro activity of imipenem, the first thienamycin antibiotic: a review of a multi-center study.
Satta G; Carlone N; Chiarini A; Cocuzza G; Covelli I; Falcone G; Campa M; Fontana R; Garaci E; Dainelli B
Chemioterapia; 1987 Jun; 6(2 Suppl):69-71. PubMed ID: 3334663
[No Abstract] [Full Text] [Related]
4. [In vitro evaluation of the antibiotic effect of imipenen on bacterial strains isolated mostly from compromised patients].
Bartolucci M; Galluzzi F; Sanchioni G; Aureli G
Quad Sclavo Diagn; 1988; 24(1-4):203-12. PubMed ID: 3268913
[TBL] [Abstract][Full Text] [Related]
5. Comparative in vitro activity of tigecycline and other antimicrobials against Gram-negative and Gram-positive organisms collected from the Asia-Pacific Rim as part of the Tigecycline Evaluation and Surveillance Trial (TEST).
Bouchillon SK; Iredell JR; Barkham T; Lee K; Dowzicky MJ
Int J Antimicrob Agents; 2009 Feb; 33(2):130-6. PubMed ID: 18995992
[TBL] [Abstract][Full Text] [Related]
6. Multidrug-resistant bacteria isolated from patients hospitalised in Intensive Care Units.
Wroblewska MM; Rudnicka J; Marchel H; Luczak M
Int J Antimicrob Agents; 2006 Apr; 27(4):285-9. PubMed ID: 16545949
[TBL] [Abstract][Full Text] [Related]
7. Tigecycline in vitro activity against gram-negative and gram-positive pathogens collected in Italy.
Roveta S; Marchese A; Debbia EA
Chemotherapy; 2008; 54(1):43-9. PubMed ID: 18073470
[TBL] [Abstract][Full Text] [Related]
8. Reversibility of antimicrobial resistance in respiratory isolates in HIV-positive Cambodian children after 36 months of HAART.
Shahum A; Benca G; Duong LS; Augustin A; Havlik S; Liska A; Kalavsky E; Beno P; Krcmery V
J Antimicrob Chemother; 2007 Jul; 60(1):194-7. PubMed ID: 17545143
[No Abstract] [Full Text] [Related]
9. Microbiology of diabetic foot infections in a teaching hospital in Malaysia: a retrospective study of 194 cases.
Raja NS
J Microbiol Immunol Infect; 2007 Feb; 40(1):39-44. PubMed ID: 17332905
[TBL] [Abstract][Full Text] [Related]
10. The postantibiotic effect (PAE) of the new penem FCE 22101 on gram-positive and -negative bacteria in vitro and in vivo.
Bergholm AM; Dornbusch K
J Chemother; 1989 Jul; 1(4 Suppl):64-6. PubMed ID: 16312306
[No Abstract] [Full Text] [Related]
11. Antimicrobial activity of tigecycline against clinical isolates from Spanish medical centers. Second multicenter study.
Betriu C; Rodríguez-Avial I; Gómez M; Culebras E; López F; Alvarez J; Picazo JJ;
Diagn Microbiol Infect Dis; 2006 Dec; 56(4):437-44. PubMed ID: 16949245
[TBL] [Abstract][Full Text] [Related]
12. In vitro potency of doripenem tested against an international collection of rarely isolated bacterial pathogens.
Jones RN; Bell JM; Sader HS; Turnidge JD; Stilwell MG
Diagn Microbiol Infect Dis; 2009 Apr; 63(4):434-9. PubMed ID: 19302927
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the antibacterial activity of lomefloxacin with that of other antibiotic/chemotherapeutic agents.
Cuffini AM; Tullio V; Vaiani G; Carlone NA
J Chemother; 1989 Jul; 1(4 Suppl):178-81. PubMed ID: 16312358
[No Abstract] [Full Text] [Related]
14. Neonatal community-acquired pneumonia: pathogens and treatment.
Wang H; Tang J; Xiong Y; Li X; Gonzalez F; Mu D
J Paediatr Child Health; 2010 Nov; 46(11):668-72. PubMed ID: 20796185
[TBL] [Abstract][Full Text] [Related]
15. Comparative activities in vitro of augmentin (amoxycillin/clavulanic acid) and oral cephalosporins.
Griffin KE; Cooper CE; Slocombe B
J Chemother; 1989 Jul; 1(4 Suppl):71-3. PubMed ID: 16312309
[No Abstract] [Full Text] [Related]
16. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
Jones RN; Sader HS; Fritsche TR; Pottumarthy S
Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
[TBL] [Abstract][Full Text] [Related]
17. A longitudinal analysis of antimicrobial susceptibility in clinical institutions in Germany as part of the Tigecycline Evaluation and Surveillance Trial (2004-2007).
Seifert H; Dowzicky MJ
Chemotherapy; 2009; 55(4):241-52. PubMed ID: 19468222
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the in vitro activity of ertapenem and nine other comparator agents against 337 anaerobic bacteria.
Behra-Miellet J; Dubreuil L; Calvet L
Int J Antimicrob Agents; 2006 Jul; 28(1):25-35. PubMed ID: 16757152
[TBL] [Abstract][Full Text] [Related]
19. [Antibiotic sensitivity of microorganisms, isolated from patients with opportunistic infections].
Tymchyk OV; Shapiro AV; Vasylenko OH
Mikrobiol Z; 2005; 67(5):64-8. PubMed ID: 16396113
[TBL] [Abstract][Full Text] [Related]
20. In vitro comparison of ciprofloxacin to parenteral antibiotics.
Speciale A; Caccamo F; Nicoletti G
J Chemother; 1989 Jul; 1(4 Suppl):154-6. PubMed ID: 16312349
[No Abstract] [Full Text] [Related]
[Next] [New Search]
